Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Changes in plasma aldosterone and renin after GLP-1 receptor agonist in obese patients with type 2 diabetes mellitus
TCTR20260123002Phase 0Recruiting
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Start
- Sep 2025
- Countries
- 1
01
Overview
Phase 0 trial in obesity and type 2 diabetes mellitus (T2DM), sponsored by Faculty of Medicine, Chiang Mai University. Primary endpoints: Change in plasma aldosterone level and Change in plasma renin level. Started Sep 2025; status: recruiting.
02
Conditions
obesitytype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20260123002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260123002.